Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Etoposide metabolism is the enzymatic biotransformation of the chemotherapy drug etoposide, which primarily targets DNA topoisomerase II (StatPearls, 2023). The process is}
Etoposide metabolism involves the CYP3A4/5-mediated O-demethylation of the parent drug to a catechol metabolite, which can be bioactivated to a reactive quinone by peroxidases or detoxified via UGT1A1-mediated glucuronidation (PubMed, PMID: 12130547, 15616150).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Etoposide metabolism.